Quantum Cyber (QUCY)
Nasdaq Market Open
Quantum Cyber N.V. is a publicly traded company focused on opportunities where quantum computing and cybersecurity overlap. Its strategy is built around the expectation that advances in quantum technology will reshape how sensitive data is protected, particularly for governments, financial institutions, communications networks, healthcare systems, energy assets, and other critical infrastructure operators.
The company’s market focus reflects a growing concern across the cybersecurity industry: sufficiently powerful quantum computers could eventually weaken or break widely used public-key encryption methods. In response, organisations are assessing post-quantum cryptography, quantum-safe key management, secure communications architectures, and other defensive tools designed to protect information over long time horizons. Quantum Cyber positions itself within this transition, seeking to develop or assemble a diversified platform that addresses emerging security risks before they become mainstream operational threats.
As an investment story, Quantum Cyber is tied less to a single established product line and more to a developing theme at the intersection of deep technology and cyber resilience. The company’s prospects depend on its ability to identify commercially relevant quantum-security applications, form partnerships, build credible technical capabilities, and convert demand for quantum-safe protection into revenue. This places it in a market that can be attractive but also highly specialised, with long adoption cycles and meaningful technology uncertainty.
For investors, Quantum Cyber N.V. represents exposure to a niche segment of the broader cybersecurity sector, centred on the future need to secure digital infrastructure against quantum-era attacks.
Last updated
- Market Cap
- —
- P/E
- —
- P/FCF
- —
- P/S
- —
- Enterprise Value
- —
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Address
- ROBERT KOCH STRASSE 50, MAINZ, 2M, 55129
Quantum Cyber Announces Plans to Establish U.S.-Based Defense-Technology Manufacturing Complex to Support Drone and Autonomous Systems Delivery
Quantum Cyber to Exhibit at Special Operations Forces Week 2026
Quantum Cyber N.V. Secures Exclusive Autonomous Drone Platform as Trump Administration Seeks $55 Billion for Drone Warfare
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q1 | 2024 Q4 | 2023 Q4 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -2.46M | — | -2.75M | — | — |
| EBITDA | -2.41M | 0 | -2.58M | 0 | 0 |
| Net income | -5.08M | — | -5M | — | — |
| Basic EPS | -0.43 | — | -1.46 | — | — |
| Diluted EPS | -0.43 | — | -1.46 | — | — |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q1 | 2024 Q4 | 2023 Q4 |
|---|---|---|---|---|---|
| Total assets | 7.72M | 5.33M | — | 13.5M | 15.41M |
| Total liabilities | 3.13M | 4.69M | — | 7.5M | 12.16M |
| Total equity | 4.59M | 641.6K | — | 6M | 3.25M |
| Cash & equivalents | 4.45M | 701.6K | — | 6.24M | 7.07M |
| Current assets | 6.6M | 4.21M | — | 8.02M | 8.98M |
| Current liabilities | 1.04M | 857.56K | — | 6.18M | 9.24M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q1 | 2024 Q4 | 2023 Q4 |
|---|---|---|---|---|---|
| Operating cash flow | -2.71M | — | -3.94M | — | — |
| Investing cash flow | -650.66K | — | -198.04K | — | — |
| Financing cash flow | 7.27M | — | -356.96K | — | — |
| Change in cash | 3.86M | — | -4.4M | — | — |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | DEF 14A — Quantum Cyber N.V. | View Filing | |
| edgar index | ARS — Quantum Cyber N.V. | View Filing | |
| edgar index | 8-K — Quantum Cyber N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Quantum Cyber N.V. | View Filing | |
| edgar index | 4 — Quantum Cyber N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | PRE 14A — Quantum Cyber N.V. | View Filing | |
| edgar index | 144 — Quantum Cyber N.V. | View Filing | |
| edgar index | 4 — Quantum Cyber N.V. | View Filing | |
| edgar index | 3 — Quantum Cyber N.V. | View Filing | |
| form 3 | Form 3 — O'Rourke Peter | View Filing | |
| edgar index | 8-K — Quantum Cyber N.V. | View Filing | |
| edgar index | 144 — Quantum Cyber N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — Quantum Cyber N.V. | View Filing | |
| edgar index | 8-K — Quantum Cyber N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — NATAN DAVID | View Filing | |
| form 4 | Form 4 — Ben-Tzvi Avraham | View Filing | |
| edgar index | 4 — Quantum Cyber N.V. | View Filing | |
| edgar index | 8-K — Quantum Cyber N.V. | View Filing | |
| edgar index | 3 — Quantum Cyber N.V. | View Filing | |
| edgar index | 3 — Quantum Cyber N.V. | View Filing | |
| edgar index | SCHEDULE 13D — Quantum Cyber N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 3 | Form 3 — NATAN DAVID | View Filing | |
| form 3 | Form 3 — Ben-Tzvi Avraham | View Filing | |
| form 4 | Form 4 — Lazar David E. | View Filing | |
| form 4 | Form 4 — Lazar David E. | View Filing | |
| form 4 | Form 4 — Lazar David E. | View Filing | |
| edgar index | 8-K — MAINZ BIOMED N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — MAINZ BIOMED N.V. | View Filing | |
| edgar index | DEF 14A — MAINZ BIOMED N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — MAINZ BIOMED N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | PRE 14A — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 8-K — MAINZ BIOMED N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 3 — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 4 — MAINZ BIOMED N.V. | View Filing | |
| form 3 | Form 3 — Lazar David E. | View Filing | |
| edgar index | S-8 — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 3 — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 4 — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 4 — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 4 — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 4 — MAINZ BIOMED N.V. | View Filing | |
| form 3 | Form 3 — Hekland Hans | View Filing | |
| form 3 | Form 3 — Hekland Hans | View Filing | |
| form 3 | Form 3 — Hekland Hans | View Filing | |
| form 3 | Form 3 — Hekland Hans | View Filing | |
| form 3 | Form 3 — Hekland Hans | View Filing | |
| edgar index | SCHEDULE 13G/A — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 8-K — MAINZ BIOMED N.V. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Lazar David E. | View Filing | |
| form 4 | Form 4 — Lazar David E. | View Filing | |
| form 4 | Form 4 — Lazar David E. | View Filing | |
| form 4 | Form 4 — Lazar David E. | View Filing | |
| form 4 | Form 4 — BAECHLER GUIDO | View Filing | |
| form 4 | Form 4 — Tibbitts Gregory J | View Filing | |
| form 4 | Form 4 — Dreismann Heinrich | View Filing | |
| form 4 | Form 4 — Caragol William J | View Filing | |
| edgar index | 8-K — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 3 — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 3 — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 3 — MAINZ BIOMED N.V. | View Filing | |
| edgar index | 3 — MAINZ BIOMED N.V. | View Filing | |
| form 3 | Form 3 — BAECHLER GUIDO | View Filing | |
| form 3 | Form 3 — BAECHLER GUIDO | View Filing | |
| form 3 | Form 3 — BAECHLER GUIDO | View Filing | |
| form 3 | Form 3 — BAECHLER GUIDO | View Filing |